Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T93703
(Former ID: TTDR00437)
|
|||||
Target Name |
Cytokine unspecific (CYK)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 2 Target-related Diseases | + | ||||
1 | Atopic eczema [ICD-11: EA80] | |||||
2 | Vasomotor/allergic rhinitis [ICD-11: CA08] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 2 Clinical Trial Drugs | + | ||||
1 | BMEC-1217B | Drug Info | Phase 1 | Allergic rhinitis | [1] | |
2 | PF-06817024 | Drug Info | Phase 1 | Atopic dermatitis | [2] | |
Mode of Action | [+] 2 Modes of Action | + | ||||
Regulator | [+] 1 Regulator drugs | + | ||||
1 | BMEC-1217B | Drug Info | [1] | |||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | PF-06817024 | Drug Info | [2] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00425971) Safety Study of Anti-Asthma Agent BMEC-1217B. U.S. National Institutes of Health. | |||||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.